Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells.

Weng C, Cai J, Wen J, Yuan H, Yang K, Imperato-McGinley J, Zhu YS.

Int J Oncol. 2013 Jan;42(1):327-37. doi: 10.3892/ijo.2012.1689. Epub 2012 Nov 6.

2.

17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.

Qiao Y, Zhang ZK, Cai LQ, Tan C, Imperato-McGinley JL, Zhu YS.

Prostate. 2007 Dec 1;67(16):1719-28.

3.

Receptor isoform and ligand-specific modulation of dihydrotestosterone-induced prostate specific antigen gene expression and prostate tumor cell growth by estrogens.

Zhu YS, Cai LQ, Huang Y, Fish J, Wang L, Zhang ZK, Imperato-McGinley JL.

J Androl. 2005 Jul-Aug;26(4):500-8; discussion 509-10.

4.
5.

Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.

Arnold JT, Le H, McFann KK, Blackman MR.

Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E573-84. Epub 2004 Nov 9.

6.

Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.

Teng J, Wang ZY, Jarrard DF, Bjorling DE.

Endocr Relat Cancer. 2008 Mar;15(1):351-64. doi: 10.1677/erc.1.01255.

7.

Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells.

Wen J, Zhao Y, Li J, Weng C, Cai J, Yang K, Yuan H, Imperato-McGinley J, Zhu YS.

Prostate. 2013 Jul;73(10):1069-81. doi: 10.1002/pros.22654. Epub 2013 Feb 19.

8.

Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism.

Cai J, Hong Y, Weng C, Tan C, Imperato-McGinley J, Zhu YS.

Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1210-21. doi: 10.1152/ajpheart.01210.2010. Epub 2011 Jan 21.

9.

Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells.

Ryan CJ, Zavodovskaya M, Youngren JF, Campbell M, Diamond M, Jones J, Shiry L, Allan G, Maddux BA, Goldfine ID.

Prostate. 2008 Aug 1;68(11):1232-40. doi: 10.1002/pros.20789.

PMID:
18491370
10.

The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment.

Stettner M, Kaulfuss S, Burfeind P, Schweyer S, Strauss A, Ringert RH, Thelen P.

Mol Cancer Ther. 2007 Oct;6(10):2626-33. Epub 2007 Oct 3.

11.

Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells.

Alexander B, Fishman AI, Green D, Choudhury MS, Konno S.

Urol Oncol. 2013 Jan;31(1):104-9. doi: 10.1016/j.urolonc.2010.11.009. Epub 2011 Jul 27.

PMID:
21795077
12.
13.
14.

Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.

Benbrahim-Tallaa L, Webber MM, Waalkes MP.

Environ Health Perspect. 2005 Sep;113(9):1134-9.

16.

Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone.

Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS, Kozlowski JM.

Endocrinology. 1995 Feb;136(2):796-803.

PMID:
7530653
17.
18.

Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2.

Rossi V, Staibano S, Abbondanza C, Pasquali D, De Rosa C, Mascolo M, Bellastella G, Visconti D, De Bellis A, Moncharmont B, De Rosa G, Puca GA, Bellastella A, Sinisi AA.

J Cell Physiol. 2009 Dec;221(3):771-7. doi: 10.1002/jcp.21920.

PMID:
19746436
19.

Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells.

Lin HY, Sun M, Lin C, Tang HY, London D, Shih A, Davis FB, Davis PJ.

J Steroid Biochem Mol Biol. 2009 Feb;113(3-5):182-8. doi: 10.1016/j.jsbmb.2008.12.010. Epub 2008 Dec 30.

PMID:
19159686
20.

Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP.

Payton-Stewart F, Schoene NW, Kim YS, Burow ME, Cleveland TE, Boue SM, Wang TT.

Mol Carcinog. 2009 Sep;48(9):862-71. doi: 10.1002/mc.20532.

Supplemental Content

Support Center